Cargando…

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

INTRODUCTION: This trial assessed safety and effectiveness of an advanced hybrid closed-loop (AHCL) system with automated basal (Auto Basal) and automated bolus correction (Auto Correction) in adolescents and adults with type 1 diabetes (T1D). MATERIALS AND METHODS: This multicenter single-arm study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlson, Anders L., Sherr, Jennifer L., Shulman, Dorothy I., Garg, Satish K., Pop-Busui, Rodica, Bode, Bruce W., Lilenquist, David R., Brazg, Ron L., Kaiserman, Kevin B., Kipnes, Mark S., Thrasher, James R., Reed, John H. Chip, Slover, Robert H., Philis-Tsimikas, Athena, Christiansen, Mark, Grosman, Benyamin, Roy, Anirban, Vella, Melissa, Jonkers, Richard A.M., Chen, Xiaoxiao, Shin, John, Cordero, Toni L., Lee, Scott W., Rhinehart, Andrew S., Vigersky, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971997/ https://www.ncbi.nlm.nih.gov/pubmed/34694909 http://dx.doi.org/10.1089/dia.2021.0319

Ejemplares similares

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023)

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
por: Brazg, Ron, et al.
Publicado: (2022)

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes
por: Philis-Tsimikas, Athena
Publicado: (2008)

Periodic Intensive Insulin Therapy Remains Experimental
por: Chang, Amy, et al.
Publicado: (2019)

Digital health tools to promote diabetes education and management of cardiovascular risk factors among under-resourced populations
por: Paul, Tenes, et al.
Publicado: (2021)

Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
por: Alva, Shridhara, et al.
Publicado: (2023)

Predictors of Dropouts From a San Diego Diabetes Program: A Case Control Study
por: Benoit, Stephen R., et al.
Publicado: (2004)

Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study
por: Benoit, Stephen R, et al.
Publicado: (2005)

100 years on: the impact of the discovery of insulin on clinical outcomes
por: Buse, John B, et al.
Publicado: (2021)

Improving Treatment of Depression Among Latinos With Diabetes Using Project Dulce and IMPACT
por: Gilmer, Todd P., et al.
Publicado: (2008)

Peer-Led Diabetes Education Programs in High-Risk Mexican Americans Improve Glycemic Control Compared With Standard Approaches: A Project Dulce promotora randomized trial
por: Philis-Tsimikas, Athena, et al.
Publicado: (2011)

Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)
por: Philis-Tsimikas, Athena, et al.
Publicado: (2013)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
por: Garg, Satish K., et al.
Publicado: (2017)

Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting
por: Fortmann, Addie L., et al.
Publicado: (2020)

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges
por: King, Allen B., et al.
Publicado: (2017)

Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials
por: Janez, Andrej, et al.
Publicado: (2020)

The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2020)

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2019)

Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico
por: Anzaldo-Campos, María Cecilia, et al.
Publicado: (2016)

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
por: Rose, Ludger, et al.
Publicado: (2019)

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
por: Zinman, Bernard, et al.
Publicado: (2012)

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation
por: Weatherall, James, et al.
Publicado: (2018)

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial
por: Mathieu, Chantal, et al.
Publicado: (2018)

Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial
por: Chaykin, Louis, et al.
Publicado: (2019)

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2022)

Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
por: Pop-Busui, Rodica
Publicado: (2010)

Pivot Teeth
por: Steel, Charles L.
Publicado: (1881)

Pivot Teeth
por: Hunter, F. L.
Publicado: (1873)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Martin, Catherine L., et al.
Publicado: (2014)

Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor
por: Christiansen, Mark P., et al.
Publicado: (2017)

Mi Puente (My Bridge) Care Transitions Program for Hispanic/Latino Adults with Multimorbidity: Results of a Randomized Controlled Trial
por: Gallo, Linda C., et al.
Publicado: (2023)

Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232
por: Jaiswal, Mamta, et al.
Publicado: (2018)

My Bridge (Mi Puente), a care transitions intervention for Hispanics/Latinos with multimorbidity and behavioral health concerns: protocol for a randomized controlled trial
por: Gallo, Linda C., et al.
Publicado: (2020)

Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes
por: Jaiswal, Mamta, et al.
Publicado: (2016)

The Pivotal Role of Women in Cardiology Sections in Medical Organizations: From Leadership Training to Personal Enrichment
por: Sharma, Garima, et al.
Publicado: (2021)

Effectiveness of Parent Education in Pivotal Response Treatment on Pivotal and Collateral Responses
por: Verschuur, Rianne, et al.
Publicado: (2019)

Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial
por: Pieber, Thomas R., et al.
Publicado: (2021)

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (BEGIN: ADD TO GLP‐1 Study)
por: Aroda, V. R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g6buf52oglqufikta21eouf00j